Prostate-specific antigen: what's new in 1997.


When used alone, prostate-specific antigen (PSA) is not sufficiently sensitive or specific to consider it an ideal tool for the early detection or staging of prostate cancer. To optimize the use of PSA, the concepts of PSA velocity, PSA density, and age-related PSA values were developed. Although PSA velocity provides excellent results, its determination… (More)


Cite this paper

@article{Pannek1997ProstatespecificAW, title={Prostate-specific antigen: what's new in 1997.}, author={J{\"{u}rgen Pannek and Alan W. Partin}, journal={Oncology}, year={1997}, volume={11 9}, pages={1273-8; discussion 1279-82} }